FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Eble

Research Profile

Disorders

Concepts & Ideas

Procedures

Anatomy

Co-author Network

Publications

TOP 3
Michael Pinkawa; Marc D Piroth; Mariana Caffaro; Victoria Djukic; Nuria Escobar-Corral; Richard Holy; Jens Klotz; Michael J Eble
Spacer stability and prostate position variability during radiotherapy for prostate cancer applying a hydrogel to protect the rectal wall.
Matthias Uhl; Baukelien van Triest; Damien C Weber; Michael J Eble; Klaus K Herfarth; Theodore L De Weese
Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: results of a multi-institutional phase II trial.
Michael Pinkawa; Felix Schoth; Andrew Sharabi; Danny Y Song; Dirk Böhmer; Gencay Hatiboglu; Michael J Eble
Current standards and future directions for prostate cancer radiation therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Eble (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michael Pinkawa; Marc D Piroth; Mariana Caffaro; Victoria Djukic; Nuria Escobar-Corral; Richard Holy; Jens Klotz; Michael J Eble
Spacer stability and prostate position variability during radiotherapy for prostate cancer applying a hydrogel to protect the rectal wall.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2013;106(2):220-4.
2013: Matthias Uhl; Baukelien van Triest; Damien C Weber; Michael J Eble; Klaus K Herfarth; Theodore L De Weese
Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: results of a multi-institutional phase II trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2013;106(2):215-9.
2013: Michael Pinkawa; Felix Schoth; Andrew Sharabi; Danny Y Song; Dirk Böhmer; Gencay Hatiboglu; Michael J Eble
Current standards and future directions for prostate cancer radiation therapy.
Expert review of anticancer therapy 2013;13(1):75-88.
2012: Michael Pinkawa; Marc D Piroth; M Caffaro; V Djukic; N Escobar-Corral; Richard Holy; J Klotz; Michael J Eble
Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer. Matched-pair analysis.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2012;188(10):917-25.
2012: Norbert Galldiks; Richard Holy; Hans J Kaiser; Karl-Josef Langen; Kay W Nolte; Michael Pinkawa; Heinz H Coenen; Michael J Eble; Christan P Filss; Gereon R Fink; Gabriele Stoffels; Marc D Piroth
Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(7):1048-57.
2012: Michael Pinkawa; Marc D Piroth; Axel Heidenreich; Richard Holy; Jens Klotz; David Pfister; Michael J Eble
Urinary morbidity after permanent prostate brachytherapy - impact of dose to the urethra vs. sources placed in close vicinity to the urethra.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2012;103(2):247-51.
2012: Marc D Piroth; S Schaar; Gabriele Stoffels; Heinz H Coenen; Norbert Galldiks; Richard Holy; H J Kaiser; J Klotz; Karl-Josef Langen; Michael Pinkawa; Michael J Eble
Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Results of a prospective phase II study.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2012;188(4):334-9.
2012: Michael Pinkawa; Marc D Piroth; Victoria Djukic; Axel Heidenreich; Richard Holy; Jens Klotz; David Pfister; Michael J Eble
Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy.
Radiation oncology (London, England) 2012;7():209.
2012: Michael Pinkawa; Marc D Piroth; Oliver H Winz; Nuria Escobar Corral; Richard Holy; Jens Klotz; Thomas Krohn; Felix M Mottaghy; Mariana Caffaro; Victoria Djukic; Michael J Eble
Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost.
Radiation oncology (London, England) 2012;7():14.
2011: Michael Pinkawa; Marc D Piroth; Felix Schoth; Nuria Escobar Corral; Mariana Caffaro; Victoria Djukic; Richard Holy; Gundula Otto; Michael J Eble
Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;100(3):436-41.
2011: Michael Pinkawa; Marc D Piroth; Dalma Székely-Orbán; Karin Fischedick; Richard Holy; Jens Klotz; Michael J Eble
Quality of life after whole pelvic versus prostate-only external beam radiotherapy for prostate cancer: a matched-pair comparison.
International journal of radiation oncology, biology, physics 2011;81(1):23-8.
2011: Michael Pinkawa; Marc D Piroth; Victoria Djukic; Richard Holy; Jens Klotz; Barbara Krenkel; Michael J Eble
Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2011;187(8):479-84.
2011: Marc D Piroth; Richard Holy; Michael Pinkawa; Gabriele Stoffels; Hans J Kaiser; Norbert Galldiks; Hans Herzog; Heinz H Coenen; Michael J Eble; Karl-Josef Langen
Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;99(2):218-24.
2011: Marc D Piroth; Michael Pinkawa; Richard Holy; Jens Klotz; Sandra Nussen; Gabriele Stoffels; Heinz H Coenen; Hans J Kaiser; Karl J Langen; Michael J Eble
Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.
International journal of radiation oncology, biology, physics 2011;80(1):176-84.
2011: Richard Holy; Marc D Piroth; Michael Pinkawa; Michael J Eble
Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2011;187(4):245-51.
2010: Michael Pinkawa; Richard Holy; Marc D Piroth; Jens Klotz; Sandra Nussen; Thomas Krohn; Felix M Mottaghy; Martin Weibrecht; Michael J Eble
Intensity-modulated radiotherapy for prostate cancer implementing molecular imaging with 18F-choline PET-CT to define a simultaneous integrated boost.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2010;186(11):600-6.
2010: Michael Pinkawa; Marc D Piroth; Richard Holy; Karin Fischedick; Sandra Schaar; Holger Borchers; Axel Heidenreich; Michael J Eble
Prostate-specific antigen kinetics following external-beam radiotherapy and temporary (Ir-192) or permanent (I-125) brachytherapy for prostate cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2010;96(1):25-9.
2010: Michael Pinkawa; Marc D Piroth; Richard Holy; Jens Klotz; Sandra Nussen; Holger Borchers; Axel Heidenreich; Michael J Eble
Rectal morbidity after permanent interstitial brachytherapy for prostate cancer--impact of day 1 vs. day 30 computed tomography-based postimplant dosimetry.
Brachytherapy 2010;9(1):1-7.
2009: Michael Pinkawa; Marc D Piroth; Karin Fischedick; Richard Holy; Jens Klotz; Sandra Nussen; Barbara Krenkel; Michael J Eble
Impact of the target volume (prostate alone vs. prostate with seminal vesicles) and fraction dose (1.8 Gy vs. 2.0 Gy) on quality of life changes after external-beam radiotherapy for prostate cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2009;185(11):724-30.
2009: Michael Pinkawa; Charbel Attieh; Marc D Piroth; Richard Holy; Sandra Nussen; Jens Klotz; Robert Hawickhorst; Wolfgang Schäfer; Michael J Eble
Dose-escalation using intensity-modulated radiotherapy for prostate cancer--evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;93(2):213-9.
2009: Marc D Piroth; Daniela M Piroth; Michael Pinkawa; Seth G Woodruff; Richard Holy; Michael J Eble
Immediate reconstruction with an expander/implant following ablatio mammae because of breast cancer : side effects and cosmetic results after adjuvant chest wall radiotherapy.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2009;185(10):669-74.
2009: Michael Pinkawa; Branka Asadpour; Marc D Piroth; Bernd Gagel; Jens Klotz; Karin Fischedick; Holger Borchers; Gerhard Jakse; Michael J Eble
Rectal dosimetry following prostate brachytherapy with stranded seeds--comparison of transrectal ultrasound intra-operative planning (day 0) and computed tomography-postplanning (day 1 vs. day 30) with special focus on sources placed close to the rectal wall.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;91(2):207-12.
2009: Michael Pinkawa; Branka Asadpour; Marc D Piroth; Bernd Gagel; Sandra Nussen; Mareike Kehl; Holger Borchers; Gerhard Jakse; Michael J Eble
Health-related quality of life after permanent I-125 brachytherapy and conformal external beam radiotherapy for prostate cancer--a matched-pair comparison.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;91(2):225-31.
2009: Michael Pinkawa; Marc D Piroth; Branka Asadpour; Bernd Gagel; Karin Fischedick; Jaroslav Siluschek; Mareike Kehl; Barbara Krenkel; Michael J Eble
Neoadjuvant hormonal therapy and external-beam radiotherapy versus external-beam irradiation alone for prostate cancer. A quality-of-life analysis.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2009;185(2):101-8.
2009: Marc D Piroth; Michael Pinkawa; Richard Holy; Gabriele Stoffels; Cengiz Demirel; Charbel Attieh; Hans J Kaiser; Karl J Langen; Michael J Eble
Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.
Radiation oncology (London, England) 2009;4():57.
2009: Michael Pinkawa; Marc D Piroth; Karin Fischedick; Sandra Nussen; Jens Klotz; Richard Holy; Michael J Eble
Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer--predictive factors on irritative symptoms, incontinence and rectal bleeding.
Radiation oncology (London, England) 2009;4():36.
2009: Michael Pinkawa; Karin Fischedick; Bernd Gagel; Marc D Piroth; Branka Asadpour; Jens Klotz; Holger Borchers; Gerhard Jakse; Michael J Eble
Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment.
BMC cancer 2009;9():296.
2009: Holger Borchers; Michael Pinkawa; Andreas Donner; Timm P Wolter; Norbert Pallua; Michael J Eble; Gerhard Jakse
Rectourethral fistula following LDR brachytherapy.
Urologia internationalis 2009;82(3):365-6.
2009: Michael Pinkawa; Bernd Gagel; Marc D Piroth; Karin Fischedick; Branka Asadpour; Mareike Kehl; Jens Klotz; Michael J Eble
Erectile dysfunction after external beam radiotherapy for prostate cancer.
European urology 2009;55(1):227-34.
2008: Michael Pinkawa; Martin Pursch-Lee; Branka Asadpour; Bernd Gagel; Marc D Piroth; Jens Klotz; Sandra Nussen; Michael J Eble
Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intrafraction organ motion.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2008;184(12):679-85.
2008: Michael Pinkawa; Bernd Gagel; Branka Asadpour; Marc D Piroth; Jens Klotz; Holger Borchers; Gerhard Jakse; Michael J Eble
Seed displacements after permanent brachytherapy for prostate cancer in dependence on the prostate level.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2008;184(10):520-5.
2008: Michael Pinkawa; Karin Fischedick; Branka Asadpour; Bernd Gagel; Marc D Piroth; Richard Holy; Barbara Krenkel; Michael J Eble
Health-related quality of life after adjuvant and salvage postoperative radiotherapy for prostate cancer - a prospective analysis.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2008;88(1):135-9.
2008: Marc D Piroth; Michael Pinkawa; Bernd Gagel; Sven Stanzel; Branka Asadpour; Michael J Eble
Sequencing chemotherapy and radiotherapy in locoregional advanced breast cancer patients after mastectomy - a retrospective analysis.
BMC cancer 2008;8():114.
2008: Michael Pinkawa; Karin Fischedick; Branka Asadpour; Bernd Gagel; Marc D Piroth; Sandra Nussen; Michael J Eble
Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer.
International journal of radiation oncology, biology, physics 2008;70(1):83-9.
2007: Marc D Piroth; Bernd Gagel; Michael Pinkawa; Sven Stanzel; Branka Asadpour; Michael J Eble
Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2007;183(12):695-702.
2007: Michael Pinkawa; Branka Asadpour; Bernd Gagel; Marc D Piroth; Holger Borchers; Gerhard Jakse; Michael J Eble
Evaluation of source displacement and dose--volume changes after permanent prostate brachytherapy with stranded seeds.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;84(2):190-6.
2007: Michael Pinkawa; Branka Asadpour; Jaroslav Siluschek; Bernd Gagel; Marc D Piroth; Cengiz Demirel; Michael J Eble
Bladder extension variability during pelvic external beam radiotherapy with a full or empty bladder.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;83(2):163-7.
2007: Bernd Gagel; Cengiz Demirel; Aline Kientopf; Michael Pinkawa; Marc D Piroth; Sven Stanzel; Christian Breuer; Branka Asadpour; Thomas Jansen; Richard Holy; Joachim E Wildberger; Michael J Eble
Active breathing control (ABC): determination and reduction of breathing-induced organ motion in the chest.
International journal of radiation oncology, biology, physics 2007;67(3):742-9.
2007: Bernd Gagel; Marc D Piroth; Michael Pinkawa; Patrick Reinartz; Michael Zimny; Hans-Juergen Kaiser; Sven Stanzel; Branka Asadpour; Cengiz Demirel; Kurt Hamacher; Heinz H Coenen; Thomas Scholbach; Payam Maneschi; Ercole Dimartino; Michael J Eble
pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia?
BMC cancer 2007;7():113.
2007: Bernd Gagel; Marc D Piroth; Michael Pinkawa; Patrick Reinartz; Thomas Krohn; Hans-Juergen Kaiser; Sven Stanzel; Christian Breuer; Branka Asadpour; Axel Schmachtenberg; Michael J Eble
Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study.
BMC cancer 2007;7():112.
2007: Michael Pinkawa; Karin Fischedick; Marc D Piroth; Bernd Gagel; Holger Borchers; Gerhard Jakse; Michael J Eble
Prostate-specific antigen kinetics after brachytherapy or external beam radiotherapy and neoadjuvant hormonal therapy.
Urology 2007;69(1):129-33.
2007: Michael Pinkawa; Jaroslav Siluschek; Bernd Gagel; Marc D Piroth; Cengiz Demirel; Branka Asadpour; Michael J Eble
Postoperative radiotherapy for prostate cancer : evaluation of target motion and treatment techniques (intensity-modulated versus conformal radiotherapy).
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2007;183(1):23-9.
2006: Michael Pinkawa; Jaroslav Siluschek; Bernd Gagel; Cengiz Demirel; Branka Asadpour; Richard Holy; Michael J Eble
Influence of the initial rectal distension on posterior margins in primary and postoperative radiotherapy for prostate cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;81(3):284-90.
2006: Michael Zimny; Bernd Gagel; Ercole Dimartino; Kurt Hamacher; Heinz H Coenen; Martin Westhofen; Michael J Eble; Udalrich Buell; Patrick Reinartz
FDG--a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer.
European journal of nuclear medicine and molecular imaging 2006;33(12):1426-31.
2006: Robert Krempien; Falk Roeder; Susanne Oertel; Marianne Roebel; Jürgen Weitz; Frank W Hensley; Carmen Timke; Angela Funk; Marc Bischof; Angelika Zabel-du Bois; Andreas G Niethammer; Michael J Eble; Markus W Buchler; Martina Treiber; Jürgen Debus
Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer.
International journal of radiation oncology, biology, physics 2006;66(4):1143-51.
2006: Michael Pinkawa; Karin Fischedick; Marc D Piroth; Bernd Gagel; Holger Borchers; Gerhard Jakse; Michael J Eble
Health-related quality of life after permanent interstitial brachytherapy for prostate cancer: correlation with postimplant CT scan parameters.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2006;182(11):660-5.
2006: Bernd Gagel; Ercole Dimartino; Oliver Schramm; Michael Pinkawa; Marc D Piroth; Cengiz Demirel; Payam Maneschi; Sven Stanzel; Branka Asadpour; Martin Westhofen; Michael J Eble
Contrast-enhanced color duplex sonography (CDS): an alternative for the evaluation of therapy-relevant tumor oxygenation?
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2006;182(10):604-9.
2006: Michael Pinkawa; Bernd Gagel; Marc D Piroth; Holger Borchers; Gerhard Jakse; Michael J Eble
Changes of dose delivery distribution within the first month after permanent interstitial brachytherapy for prostate cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2006;182(9):525-30.
2006: Michael Pinkawa; Karin Fischedick; Bernd Gagel; Marc D Piroth; Holger Borchers; Gerhard Jakse; Michael J Eble
Association of neoadjuvant hormonal therapy with adverse health-related quality of life after permanent iodine-125 brachytherapy for localized prostate cancer.
Urology 2006;68(1):104-9.
2006: Bernd Gagel; Marc D Piroth; Michael Pinkawa; Patrick Reinartz; Michael Zimny; Karin Fischedik; Sven Stanzel; Christian Breuer; Erik Skobel; Branka Asadpour; Axel Schmachtenberg; Udalrich Buell; Michael J Eble
Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2006;182(5):263-9.
2006: Susanne Oertel; Martina Treiber; Anita Zahlten-Hinguranage; Steffen Eichin; Falk Roeder; Angela Funk; Frank W Hensley; Carmen Timke; Andreas G Niethammer; Peter E Huber; Jürgen Weitz; Michael J Eble; Markus W Buchler; Ludger Bernd; Jürgen Debus; Robert Krempien
Intraoperative electron boost radiation followed by moderate doses of external beam radiotherapy in limb-sparing treatment of patients with extremity soft-tissue sarcoma.
International journal of radiation oncology, biology, physics 2006;64(5):1416-23.
2006: Michael Pinkawa; Karin Fischedick; Branka Asadpour; Bernd Gagel; Marc D Piroth; Michael J Eble
Low-grade toxicity after conformal radiation therapy for prostate cancer--impact of bladder volume.
International journal of radiation oncology, biology, physics 2006;64(3):835-41.
2006: Michael Pinkawa; Branka Asadpour; Bernd Gagel; Marc D Piroth; Richard Holy; Michael J Eble
Prostate position variability and dose-volume histograms in radiotherapy for prostate cancer with full and empty bladder.
International journal of radiation oncology, biology, physics 2006;64(3):856-61.
2006: Bernd Gagel; Patrick Reinartz; Cengiz Demirel; Hans-Juergen Kaiser; Michael Zimny; Marc D Piroth; Michael Pinkawa; Sven Stanzel; Branka Asadpour; Kurt Hamacher; Heinz H Coenen; Udalrich Buell; Michael J Eble
[18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study.
BMC cancer 2006;6():51.
2006: Michael Pinkawa; Karin Fischedick; Peter Treusacher; Branka Asadpour; Bernd Gagel; Marc D Piroth; Holger Borchers; Gerhard Jakse; Michael J Eble
Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;78(1):41-6.
2006: Susanne Oertel; Andreas G Niethammer; Robert Krempien; Falk Roeder; Michael J Eble; Claudia Baer; Peter E Huber; Andreas E Kulozik; Karl-Ludwig Waag; Martina Treiber; Jürgen Debus
Combination of external-beam radiotherapy with intraoperative electron-beam therapy is effective in incompletely resected pediatric malignancies.
International journal of radiation oncology, biology, physics 2006;64(1):235-41.
2004: Bernd Gagel; Patrick Reinartz; Ercole Dimartino; Michael Zimny; Michael Pinkawa; Payam Maneschi; Sven Stanzel; Kurt Hamacher; Heinz H Coenen; Martin Westhofen; Udalrich Büll; Michael J Eble
pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2004;180(10):616-22.
2004: Holger Borchers; Ruth Kirschner-Hermanns; Bernhard Brehmer; Lothar Tietze; Thorsten Reineke; Michael Pinkawa; Michael J Eble; Gerhard Jakse
Permanent 125I-seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results.
BJU international 2004;94(6):805-11.
2004: Stefan Höcht; Riad Hammad; H Thiel; Thomas Wiegel; Alessandra Siegmann; J Willner; Peter Wust; Thomas Herrmann; Michael J Eble; D Carstens; Michael Flentje; P Neumann; Wolfgang Hinkelbein
A multicenter analysis of 123 patients with recurrent rectal cancer within the pelvis.
Frontiers of radiation therapy and oncology 2004;38():41-51.
2004: Stefan Höcht; Riad Hammad; Hans-Joachim Thiel; Thomas Wiegel; Alessandra Siegmann; Jochen Willner; Peter Wust; Thomas Herrmann; Michael J Eble; Michael Flentje; Detlef Carstens; Dirk Bottke; Patrick Neumann; Wolfgang Hinkelbein
Recurrent rectal cancer within the pelvis. A multicenter analysis of 123 patients and recommendations for adjuvant radiotherapy.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2004;180(1):15-20.
2003: Ercole Di Martino; Bernd Gagel; Oliver Schramm; Gabriele A Krombach; Payam Maneschi; Michael J Eble; Martin Westhofen
[Sonografic evaluation of oxygenation in head and neck cancer].
Laryngo- rhino- otologie 2003;82(11):775-81.
2003: Michael Pinkawa; Bernd Gagel; Cengiz Demirel; Axel Schmachtenberg; Branka Asadpour; Michael J Eble
Dose-volume histogram evaluation of prone and supine patient position in external beam radiotherapy for cervical and endometrial cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;69(1):99-105.
2003: Michael van Kampen; Michael J Eble; Robert Krempien; Katrin Jensen; Barbar Aydenitz; Martin Metzger; Frank W Hensley; Sabine Haufe; Folker Amelung; Diethelm Wallwiener; Michael Wannenmacher
Influence of irradiated volume on ureteral injury after intraoperative radiation therapy: experimental study in dogs.
Radiology 2003;228(1):139-43.
2003: Eduard Ryschich; Wolfgang Harms; Thorsten Loeffler; Michael J Eble; Ernst Klar; Jan Schmidt
Radiation-induced leukocyte adhesion to endothelium in normal pancreas and in pancreatic carcinoma of the rat.
International journal of cancer. Journal international du cancer 2003;105(4):506-11.
2003: Michael Pinkawa; Uwe Maurer; Andrew Mulhern; Bernd Gagel; Thomas Block; Holger Borchers; Johannes Grieger; Thomas Henkel; Michael J Eble
Inverse automated treatment planning with and without individual optimization in interstitial permanent prostate brachytherapy with high- and low-activity 125I.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2003;179(6):417-22.
2003: Eduard Ryschich; Jan Schmidt; Thorsten Loeffler; Michael J Eble; Martha Maria Gebhard; Wolfgang Harms; Ernst Klar
Different radiogenic effects on microcirculation in healthy pancreas and in pancreatic carcinoma of the rat.
Annals of surgery 2003;237(4):515-21.
2003: Sylvia Kinzel; Sven Hein; Thaddeus Stopinski; Johannes Koch; Arno Buecker; Hans-Peter Treusacher; Axel Schmachtenberg; Thomas Jansen; Michael J Eble; Werner Küpper
[Hypofractionated radiation therapy for the treatment of malignant melanoma and squamous cell carcinoma in dogs and cats].
Berliner und Münchener tierärztliche Wochenschrift 2003;116(3-4):134-8.
2002: Bernd Gagel; Oliver Schramm; Wolfgang Harms; Andrew Mulhern; Frederik Wenz; Michael van Kampen; Michael Wannenmacher; Michael J Eble
The electronic portal imaging system Siemens Beamview Plus versus the conventional verification films CEA-TVS and DuPont COL-7. A critical appraisal of visual image quality.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2002;178(8):446-52.
2002: Michael J Eble; U Maurer
Is radiotherapy of pelvic lymph nodes successful in prostate cancer?
Frontiers of radiation therapy and oncology 2002;36():43-8.
2002: U Maurer; Thomas Wiegel; Wolfgang Hinkelbein; Michael J Eble
Interstitial brachytherapy with permanent seed implants in early prostate cancer.
Frontiers of radiation therapy and oncology 2002;36():166-70.
2002: U Maurer; Michael J Eble
The technique of 125I permanent implants.
Frontiers of radiation therapy and oncology 2002;36():159-65.
2001: Michael van Kampen; Michael J Eble; Thomas Lehnert; Ludger Bernd; K Jensen; Frank W Hensley; Robert Krempien; Michael Wannenmacher
Correlation of intraoperatively irradiated volume and fibrosis in patients with soft-tissue sarcoma of the extremities.
International journal of radiation oncology, biology, physics 2001;51(1):94-9.
2000: Volker Rudat; Bernhard Vanselow; P Wollensack; C Bettscheider; S Osman-Ahmet; Michael J Eble; Andreas Dietz
Repeatability and prognostic impact of the pretreatment pO(2) histography in patients with advanced head and neck cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2000;57(1):31-7.
2000: G Sauer; Klaus-Josef Weber; Peter Peschke; Michael J Eble
Measurement of hypoxia using the comet assay correlates with preirradiation microelectrode pO2 histography in R3327-AT rodent tumors.
Radiation research 2000;154(4):439-46.
2000: Bernhard Vanselow; Michael J Eble; Volker Rudat; P Wollensack; Christian Conradt; Andreas Dietz
Oxygenation of advanced head and neck cancer: prognostic marker for the response to primary radiochemotherapy.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2000;122(6):856-62.
2000: Desiderius Sabo; Dario R C Brocai; Michael J Eble; Michael Wannenmacher; Volker Ewerbeck
Influence of extracorporeal irradiation on the reintegration of autologous grafts of bone and joint. Study in a canine model.
The Journal of bone and joint surgery. British volume 2000;82(2):276-82.
1999: Andreas Dietz; Volker Rudat; Bernhard Vanselow; P Wollensack; C Bettscheider; Christian Conradt; Michael J Eble
Rise of oxygenation in cervical lymph node metastasis during the initial course of radiochemotherapy.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1999;121(6):789-96.
1999: Desiderius Sabo; Ludger Bernd; Volker Ewerbeck; Michael J Eble; Michael Wannenmacher; M Schulte
[Intraoperative extracorporeal irradiation and replantation (EIR) in the treatment of primary malignant bone tumors].
Der Unfallchirurg 1999;102(7):580-8.
1998: Michael J Eble; Thomas Lehnert; Martina Treiber; Detlev Latz; C Herfarth; Michael Wannenmacher
Moderate dose intraoperative and external beam radiotherapy for locally recurrent rectal carcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1998;49(2):169-74.
1998: Detlev Latz; Katharina Fleckenstein; Michael J Eble; Johannes Blatter; Michael Wannenmacher; Klaus-Josef Weber
Radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) within the cell cycle in vitro.
International journal of radiation oncology, biology, physics 1998;41(4):875-82.
1998: Michael J Eble; Michael Wannenmacher
[Topical radiotherapy in the management of skeletal metastases].
Der Orthopäde 1998;27(4):245-9.
1998: Matthias H M Schwarzbach; Frank Willeke; Michael J Eble; M Wannenmacher; T Lehnert; Christian Herfarth
[Morbidity and tumor control in limb-saving resection with intraoperative radiotherapy in a multimodality therapy concept in soft tissue sarcoma].
Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 1998;115():1312-5.
1998: Michael J Eble; Gerd Staehler; Michael Wannenmacher
[The intraoperative radiotherapy (IORT) of locally spread and recurrent renal-cell carcinomas].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1998;174(1):30-6.
1997: Bernhard Vanselow; Andreas Dietz; Volker Rudat; P Wollensack; C Bettscheider; Michael J Eble
[Polarographic detection of reoxygenation of lymph node metastases in the initial phase of primary radio- and radiochemotherapy in patients with advanced squamous epithelial carcinomas of the head and neck].
HNO 1997;45(3):140-6.
1997: Michael J Eble; Diethelm Wallwiener; Hans Junkermann; H Schmid; Erich Solomayer; Eva-Maria Grischke; Michael Wannenmacher; Gunther Bastert
Tumor debulking and IORT for recurrent gynecological carcinomas of the pelvic sidewall.
Frontiers of radiation therapy and oncology 1997;31():263-6.
1997: Michael J Eble; G Stähler; Michael Wannenmacher
IORT for locally advanced or recurrent renal cell carcinoma.
Frontiers of radiation therapy and oncology 1997;31():253-5.
1997: Michael J Eble; Martina Treiber; Thomas Lehnert; C Herfarth; Michael Wannenmacher
IORT for recurrent rectal carcinoma.
Frontiers of radiation therapy and oncology 1997;31():229-33.
1997: Michael J Eble; Thomas Lehnert; C Herfarth; Michael Wannenmacher
IORT as adjuvant treatment in primary rectal carcinomas: multi-modality treatment.
Frontiers of radiation therapy and oncology 1997;31():200-3.
1997: Michael J Eble; Thomas Lehnert; Matthias H M Schwarzbach; V Ewerbeck; C Herfarth; Michael Wannenmacher
IORT for extremity sarcomas.
Frontiers of radiation therapy and oncology 1997;31():146-50.
1997: M Metzger; Michael J Eble; Frank W Hensley
3-D dose reconstruction in IORT.
Frontiers of radiation therapy and oncology 1997;31():51-3.
1996: Michael J Eble; U Maurer
[Intraoperative and percutaneous radiotherapy of pancreatic carcinoma].
Der Radiologe 1996;36(5):441-5.
1996: Matthias H M Schwarzbach; Frank Willeke; Michael J Eble; Thomas Lehnert; Volker Ewerbeck; Michael Wannenmacher; Christian Herfarth
[Intraoperative radiotherapy in advanced soft tissue sarcoma of the extremities].
Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 1996;113():214-7.
1995: Frank Willeke; Michael J Eble; Thomas Lehnert; Matthias H M Schwarzbach; Ulf Hinz; Michael Wannenmacher; Christian Herfarth
[Intraoperative radiotherapy within the treatment concept of retroperitoneal soft tissue sarcomas].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 1995;66(9):899-904.
1995: M van Kampen; J Wulf; Michael J Eble; Volker Rudat; G Gademann; W Schlegel; Michael Wannenmacher
[Three-dimensional planned radiotherapy in rectal cancer. Feasibility study and preliminary clinical results].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1995;171(2):87-93.
1995: Michael J Eble; J Wulf; M van Kampen; U Weischedel; Michael Wannenmacher
[Locally restricted dose escalation in radiotherapy of primary advanced and recurrent rectal cancers].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1995;171(2):77-86.
1994: Michael J Eble; Frank W Hensley; Michael Flentje; A Schlotz; Michael Wannenmacher
A modified computer-assisted colorimetric microtitre assay (MTT) to assess in vitro radiosensitivity of V79, CaSki, HeLa and WiDr cells.
International journal of radiation biology 1994;65(2):193-201.
1994: T W Kraus; Michael J Eble; Ulrich Raeth
[Developments up to now and current status of adjuvant chemo- and radiotherapy in colonic and rectal carcinoma].
Langenbecks Archiv für Chirurgie 1994;379(6):353-7.
1993: Michael J Eble; A Quentmeier; Volker Ewerbeck; C Herfarth; Michael Wannenmacher
[Methodology, technical prerequisites and postoperative morbidity of intraoperative radiotherapy (IORT) of soft tissue sarcomas. Heidelberg Krankengut 6/91-9/92].
Der Radiologe 1993;33(9):513-9.
1993: Michael J Eble; G Gademann; Michael Wannenmacher
[The value of radiotherapy for liver metastases].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1993;169(8):459-68.
1993: Michael J Eble; C Herfarth; M Wannenmacher
[Fundamentals and possibilities of intraoperative radiotherapy].
Deutsche medizinische Wochenschrift (1946) 1993;118(26):981-5.
1993: Detlev Latz; P Schraube; Michael J Eble
[The primary radiotherapy of inoperable or recurrent pancreatic carcinoma--Heidelberg patients from 1982 to 1992].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1993;169(7):387-93.
1992: Michael Wannenmacher; Michael J Eble; K Rieden
[Possibilities and value of radiotherapy of osseous metastases].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 1992;63(11):923-30.
1992: Michael Flentje; Michael J Eble; U Haner; S Trinh; Michael Wannenmacher
Additive effects of cisplatin and radiation in human tumor cells under oxic conditions.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1992;24(1):60-3.
1991: Detlev Latz; Michael Flentje; Michael J Eble; A Hör; M Wannenmacher
[Effects of lonidamine alone or in combination with radiotherapy on survival and metabolism in human and rodent cell lines].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1991;167(12):716-22.